Wilson Gavin G - OmicsDI

Show results for

Unknown (16)
Genomics (6)
Transcriptomics (4)
Metabolomics (3)

Organisms

Homo sapiens (7)
Hordeum vulgare (1)
Caenorhabditis elegans (1)
Triticum aestivum (1)

Repository

biostudies-arrayexpress (5)
EGA (5)
MetaboLights (3)

Disease

Colon adenocarcinoma (2)

Technology Type

Mass spectrometry (3)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - negative - hilic (2)
Liquid Chromatography MS - positive - hilic (2)
Liquid Chromatography MS – positive - reverse phase (1)
Liquid Chromatography MS – negative - hilic (1)
Liquid Chromatography MS - alternating (1)

Publication Date

2023 (3)
2011 (2)
2006 (2)
2014 (1)

CHEBI ID

CHEBI:2666 (2)
CHEBI:174850 (2)
CHEBI:46659 (2)
CHEBI:34690 (2)
CHEBI:27402 (2)
CHEBI:9093 (2)
CHEBI:10444 (2)
CHEBI:3746 (2)
CHEBI:3219 (2)
CHEBI:2453 (2)
CHEBI:177282 (2)
CHEBI:168124 (2)
CHEBI:7856 (2)
CHEBI:27827 (2)
CHEBI:17401 (2)
CHEBI:10049 (2)
CHEBI:36491 (2)
CHEBI:38940 (2)
CHEBI:27701 (2)
CHEBI:8497 (2)
CHEBI:28283 (2)
CHEBI:10082 (2)
CHEBI:80127 (2)
CHEBI:16871 (2)
CHEBI:9342 (2)
CHEBI:7494 (2)
CHEBI:3077 (2)
CHEBI:45980 (2)
CHEBI:5557 (2)
CHEBI:31648 (2)

Metabolite Name

Laurylaldehyde (2)
(S)-3-Hydroxyhexadecanoyl-CoA (2)
Undecan-2-one (2)
Clindamycin phosphate (2)
Bupropion (2)
Ipratropium bromide (2)
Myo-inositol hexakisphosphate (2)
Cyanidin 3-glucoside (2)
Sinensal (2)
Prenol (2)
Selenocysteine (2)
Aciclovir (2)
Ibutilide (2)
Palmitaldehyde (2)
2-Methoxy-estradiol-17b 3-glucuronide (2)
Agmatine (2)
Guanethidine (2)
Angiotensin IV (2)
5-Methyltetrahydrofolic acid (2)
Sulindac (2)
Haloperidol (2)
Butanal (2)
Xanthosine 5-triphosphate (2)
Beta-D-3-Ribofuranosyluric acid (2)
Phytol (2)
Thiamine monophosphate (2)
Pentadecanal (2)
Cysteic acid (2)
Cyclic GMP (2)
Nicardipine (2)

Study type

Unknown experiment type (2)
Transcription profiling by array (2)
ChIP-seq (1)

Release Date

2023 (3)
2021 (3)
2015 (3)
2011 (2)
2006 (2)
2019 (2)
2016 (2)
2014 (1)
2022 (1)
2018 (1)
2017 (1)

Previous page
1 / 3
You're on page 1
page 2
page 3
Next page

Sort by:

Relevance

Page size

Himalaya v 292

Himalaya v 292 Four biological replicates were used for the comparison and the dyes were swapped among the test and control samples for labeling two of the replicates. For each replicate, 50 ?g of total RNA was used for both the Cy3 and Cy5 dyes (Amersham Pharmacia, UK), following the two-step label...

ORGANISM(S): Hordeum vulgare

2006-07-24 | E-GEOD-5368 | biostudies-arrayexpress

Grain Hardness

A microarray analysis of wheat grain hardness For both the Heron and Falcon NIL, whole wheat heads were harvested at 6, 15 and 25 days post anthesis (DPA) from glass house grown material and stored at -80 OC. For the other wheat cultivars analysed, heads at approximately 9-10 DPA were used. Eight to...

ORGANISM(S): Triticum aestivum

2006-07-24 | E-GEOD-5369 | biostudies-arrayexpress

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility.

Not available

S-EPMC6366343 | biostudies-literature

Strategic analysis of the drought resilience of water supply systems

Not available

S-EPMC9588422 | biostudies-literature

Airway Dysbiosis Accelerates Lung Function Decline in Chronic Obstructive Pulmonary Disease (Murine UPLC-MS/MS assays)

Progressive lung function decline is a hallmark of chronic obstructive pulmonary disease (COPD). Airway dysbiosis occurs in COPD, but whether it contributes to disease progression remains unknown. Here we showed, through a longitudinal analysis on two cohorts involving four UK centers, that basel...

2023-06-12 | MTBLS6894 | MetaboLights

Airway Dysbiosis Accelerates Lung Function Decline in Chronic Obstructive Pulmonary Disease (Human UPLC-MS/MS assays)

Progressive decline in lung function is a hallmark of chronic obstructive pulmonary disease (COPD). Although airway dysbiosis occurs in COPD, whether it contributes to disease progression remains unknown. Here, through a longitudinal analysis on 181 COPD individuals from two large cohorts involvi...

2023-06-12 | MTBLS5423 | MetaboLights

TDP-1, the C. elegans ortholog of TDP-43, limits the accumulation of double stranded RNA

C. elegans mutants deleted for TDP-1, an ortholog of the neurodegeneration-associated RNA binding protein TDP-43, display only mild phenotypes. Nevertheless, transcriptome sequencing revealed that many RNAs were altered in accumulation and/or processing in the mutant. Analysis of these transcription...

ORGANISM(S): Caenorhabditis elegans

2014-11-19 | E-GEOD-61581 | biostudies-arrayexpress

Simultaneously discovering the fate and biochemical effects of pharmaceuticals through untargeted metabolomics

Untargeted metabolomics is an established approach in toxicology for characterising endogenous metabolic responses to xenobiotic exposure. Detecting the xenobiotic and its biotransformation products as part of the metabolomics analysis provides an opportunity to simultaneously gain deep insights int...

2023-07-03 | MTBLS2746 | MetaboLights

Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer using Formalin Fixed Paraffin Embedded Tissue_Validation Set

Current prognostic factors are poor at identifying patients at risk of disease recurrence following surgery for stage II colon cancer. Here we describe a DNA microarray based prognostic assay using clinically relevant formalin fixed paraffin embedded (FFPE) samples.

ORGANISM(S): Homo sapiens

2011-11-22 | E-MTAB-864 | biostudies-arrayexpress

Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer using Formalin Fixed Paraffin Embedded Tissue_Training Set